J&J falls after appeals court rules company can't use bankruptcy to end cancer suits (update)

Jan. 30, 2023 4:32 PM ETJohnson & Johnson (JNJ)By: Joshua Fineman, SA News Editor126 Comments

Amino acid pills and powder on white marble table, flat lay

Liudmila Chernetska/iStock via Getty Images

Update 4:30pm: Adds closing share price.

Johnson & Johnson (NYSE:JNJ) fell 3.7% after an appeals court ruled against the pharmaceuticals giant in a talc case covering more than 40,000 lawsuits. The stock decline

Recommended For You

Comments (126)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.